en
Scientific article
Open access
English

Lipodystrophy Increases the Risk of CKD Development in HIV-Positive Patients in Switzerland: The LIPOKID Study

Published inKidney International Reports, vol. 3, no. 5, p. 1089-1099
Publication date2018
Abstract

Antiretroviral therapy has improved the life expectancy of patients living with HIV. However, lipodystrophy syndrome (LD) remains prevalent, affecting mostly patients treated with first-generation antiretroviral drugs. This syndrome is characterized by changes in body fat distribution with or without associated metabolic changes. Here, we studied whether clinically evaluated LD is independently associated with chronic kidney disease (CKD) development (sustained estimated glomerular filtration rate [eGFR] < 60 ml/min per 1.73 m2) in HIV-positive patients.

Funding
  • Swiss National Science Foundation - 148522
Citation (ISO format)
BOUATOU, Yassine et al. Lipodystrophy Increases the Risk of CKD Development in HIV-Positive Patients in Switzerland: The LIPOKID Study. In: Kidney International Reports, 2018, vol. 3, n° 5, p. 1089–1099. doi: 10.1016/j.ekir.2018.04.014
Main files (1)
Article (Published version)
Identifiers
ISSN of the journal2468-0249
367views
135downloads

Technical informations

Creation11/16/2018 8:24:00 AM
First validation11/16/2018 8:24:00 AM
Update time03/15/2023 4:03:54 PM
Status update03/15/2023 4:03:53 PM
Last indexation05/03/2024 8:07:22 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack